Observations placeholder
Dapsone
Identifier
018844
Type of Spiritual Experience
Background
A description of the experience
Dapsone, also known as diaminodiphenyl sulfone (DDS), is an antibiotic commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. It is a second-line medication for the treatment and prevention of Pneumocystis pneumonia and for the prevention of toxoplasmosis in those who have poor immune function. Additionally, it has been used for acne as well as other skin conditions. Dapsone is available both topically and by mouth.
Severe side effects may include: a decrease in blood cells, red blood cell breakdown especially in those with glucose-6-phosphate dehydrogenase deficiency (G-6-PD), or hypersensitivity. Common side effects include nausea and loss of appetite. Other side effects include liver inflammation and a number of types of skin rashes. While it is not entirely clear the safety of use during pregnancy some physicians recommend that it be continued in those with leprosy. It is of the sulfone class.
Dapsone was first studied as an antibiotic in 1937. Its use for leprosy began in 1945.
On Dec, 1, 2015: 3,844 people reported to have side effects when taking Dapsone. Among them, 15 people (0.39%) have Hallucination.
On Nov, 29, 2015: 3,844 people reported to have side effects when taking Dapsone. Among them, 64 people (1.66%) have Death.
Time on Dapsone when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death16.67%22.22%27.78%11.11%22.22%0.00%0.00%